China’s IPO Tightening Adds To Uncertainties Over Biotechs Going Public

 
• By Dexter Jie Yan
  
go public
Going public has become even more challenging for Chinese biotechs in a depressed stock market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia